Leopold Bertea

Company: Mendus

Job title: Chief Technology Officer

Seminars:

Case Study: Leveraging Dendritic Cell Biology to Improve NK-cell Based Therapeutic Approaches 9:00 am

Dendritic cell biology can be used to improve NK-cell based therapeutic approaches Intratumoral allogeneic dendritic cells activate NK cells and broader antitumour immune responses Leukemic-derived dendritic cells can be used to expand memory NK cells for therapeutic purposesRead more

day: Conference Day One